1. Home
  2. SEAT vs MLYS Comparison

SEAT vs MLYS Comparison

Compare SEAT & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

N/A

Current Price

$6.82

Market Cap

82.9M

Sector

Industrials

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$37.26

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEAT
MLYS
Founded
2001
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.9M
3.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SEAT
MLYS
Price
$6.82
$37.26
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$32.94
$46.40
AVG Volume (30 Days)
136.0K
1.4M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$643,775,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.26
$8.24
52 Week High
$100.00
$47.65

Technical Indicators

Market Signals
Indicator
SEAT
MLYS
Relative Strength Index (RSI) 35.19 42.87
Support Level $6.26 $35.73
Resistance Level $7.98 $39.15
Average True Range (ATR) 0.57 1.87
MACD 0.10 -0.37
Stochastic Oscillator 28.57 18.37

Price Performance

Historical Comparison
SEAT
MLYS

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: